Critical insights into the evolving drug-approval process in China

Cancer. 2024 Mar 1;130(5):665-667. doi: 10.1002/cncr.35186. Epub 2024 Jan 2.

Abstract

Efforts have been put forward to improve the therapeutic development process in China and more novel therapies have been approved in recent years. It is important to develop and test novel therapies in China given differences in metabolism and tolerance compared to other populations.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • China / epidemiology
  • Drug Approval*
  • Humans
  • United States
  • United States Food and Drug Administration